Stonebrook Private’s Amgen AMGN Stock Holding History

Stonebrook Private’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$307K	Buy	848 +67	+9%	+$22.9K	0.06%	180
2026 Q1	$275K	Buy	781 +88	+13%	+$31.4K	0.06%	174
2025 Q4	$227K	Buy	+693	New	+$220K	0.05%	183

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Stonebrook Private's AMGN Position: Q2 2026 in Review

Stonebrook Private increased its Amgen (AMGN) stake by 8.6% in Q2 2026, buying an estimated $22.9K and bringing the position to 848 shares worth $307K. The position accounts for 0.06% of the portfolio, ranked #180.

Stonebrook Private first reported a position in AMGN in Q4 2025 and has held it in 3 quarters since. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Stonebrook Private held 848 shares of Amgen worth $307K as of Q2 2026.
Stonebrook Private bought 67 Amgen shares in Q2 2026, an estimated $22.9K.
Amgen made up 0.06% of Stonebrook Private's portfolio in Q2 2026, its #180 holding.
Stonebrook Private first reported a position in Amgen in Q4 2025 and has held it in 3 quarters since.
3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Stonebrook Private's 13F filing for Q2 2026, filed 14 Aug 2026.